$恒生指數(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$榮昌生物(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $三葉草生物-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$維亞生物(01873.HK)$...
$開拓藥業-B(09939.HK)$ With the opening up, it is inevitable the Covid cases will jump into hundreds of thousand. This is where this covid treatment drug will greatly benefit along with some of the other approved Covid treatments
The latest US effort to reduce reliance on China is striking hard at the Asian nation’s biotech stocks, as investors price in more indications of decoupling between the world’s two biggest economies. Following US President Joe Biden’s executive order to bolster domestic bio-manufacturing and cut reliance on foreign companies, bellwether Chinese stocks such as$藥明生物(02269.HK)$Wuxi Biologics Cayman Inc. and$藥明康德(02359.HK)$WuXi AppT...
開拓藥業-B股票討論區
HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off
Pharmaceuticals were sold off. $榮昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三葉草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亞生物(01873.HK)$ ...
專欄港股收評:恆生科技指數跌0.22%,恆指失守2萬點,黃金、航空、旅遊大跌
今日,港股午後現V型走勢,$恒生科技指數(800700.HK)$ 一度大跌1.7%,尾盤拉昇近乎翻紅,最終下跌0.22%,h$恒生指數(800000.HK)$ 、$國企指數(800100.HK)$ 分別跌0.58%和0.46%,恆指跌115點失守2萬點關口。南下資金全日淨流入17.46億港元,大市成交額不足千億港元。
盤面上,大型科技股多數下跌,$騰訊控股(00700.HK)$ 、$阿里巴巴-SW(09988.HK)$ 、$小米集團-W(01810.HK)$ 均跌超1%,$快手-W(01024.HK)$ 漲3%,$網易-S(09999.HK)$ 漲1.2%;國際金價4月以來首次失守1980美元,黃金股全線回撤,房地產仍沒有明顯的復甦上升態勢,內房股與物管股攜手走低,家電股、鋼鐵股等產業鏈股齊挫,拜登欲限製美企對華投資,半導體股全天表現...
With the opening up, it is inevitable the Covid cases will jump into hundreds of thousand. This is where this covid treatment drug will greatly benefit along with some of the other approved Covid treatments
US efforts to boost biotech industry lead to China selloff
Following US President Joe Biden’s executive order to bolster domestic bio-manufacturing and cut reliance on foreign companies, bellwether Chinese stocks such as $藥明生物(02269.HK)$ Wuxi Biologics Cayman Inc. and $藥明康德(02359.HK)$ WuXi AppT...
Kintor soared on news of Covid-19 drug efficacy.
港股開拓藥業大跌67%
公司公告稱口服新冠藥普克魯胺的三期中期分析未達統計學顯著性,將尋求修改臨床試驗方案。
$開拓藥業-B(09939.HK)$
專欄不段说:meta/fb都簽了他們?!元宇宙概念還有調整買入機會嗎?
4:25 unity业绩被错待,为什么元宇宙重要股有它?u.us 、mttr.us $Unity Software(U.US)$ $Matterport(MTTR.US)$ $Meta Platforms(FB.US)$ $英偉達(NVDA.US)$
19:46 元宇宙投资周期到底有多长?
22:00 为什么说疫苗相关股的逻辑被破坏掉了?腾盛(2137) $騰盛博藥-B(02137.HK)$ 开拓药业(9939) $開拓藥業-B(09939.HK)$ $輝瑞(PFE.US)$
29:43 QA 保利协鑫(3800) $協鑫科技(03800.HK)$ 、片仔癀(600436) $片仔癀(600436.SH)$
$藥品(BK1067.HK)$
$復星國際(00656.HK)$
$開拓藥業-B(09939.HK)$
$藥品(BK1067.HK)$
$復星國際(00656.HK)$
$開拓藥業-B(09939.HK)$
暫無評論